★★★★★ 4
Cooling pillows case
Color: 01 - Light Grey
Not bad good fit
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 28, 2025
his and hers semaglutide Hims & Hers offers compounded Wegovy for $99 a month to select professions
Marsoni
M251S
Get it in 3 business days with 1 day shipping.
Friday, May 29
DPP 4, SGLT 2 & GLP 1 Meet Retatrutide: The Unapproved Cousin Of Ozempic That Supports Weight Loss Differently Health and Me The Weight Loss Breakthrough Everyone's Talking About: Semaglutide & Tirzepatide at Santa Ana Skin Care Santa Ana Skin Care Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers Fortune
Quick Dispatch:
Your his and hers semaglutide Hims & Hers offers compounded Wegovy for $99 a month to select professions orders ship within 1-2 business days.
Delivery Options:
- Standard: 3-7 business days
- Fast: 2-3 business days
- Express: 1-2 business days
Order Tracking:
You'll receive a tracking link by email once your his and hers semaglutide Hims & Hers offers compounded Wegovy for $99 a month to select professions ships.
Need Help?
Questions about his and hers semaglutide Hims & Hers offers compounded Wegovy for $99 a month to select professions, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for his and hers semaglutide Hims & Hers offers compounded Wegovy for $99 a month to select professions in your area.
Get Shipping Estimates
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
Novo Nordisk hits out at rival Hims & Hers over cheaper weight-loss pill
23.54
Novo Nordisk ends Hims & Hers partnership over knockoff Wegovy
20.13
Telehealth company Hims & Hers cancels $49 monthly weight loss drug launch following FDA warnings about unapproved semaglutide compounds and Novo threats
24.78
Novo Nordisk Shares Rise, Hims & Hers Falls After Wegovy Copy Is Pulled
23.19
Hims Tumbles 19% After CEO Says It's Phasing Out Weight Loss Copies
24.86
Hims & Hers abandons copycat weight-loss drug in face of FDA probe
20.07
Novo Nordisk drops its Hims & Hers patent lawsuit as Wegovy and Ozempic head to the Hims platform
25.15
4.4 ★★★★★
Based on 1218 reviews
Sort
Product Reviews
★★★★★ 5
Very cold
Color: 01 - Light Grey
Super cold
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 25, 2026
★★★★★ 5
Cool pillow vase
Color: 01 - Light Grey
Nice cool material and stays kn the pillow well due to the snaps.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 21, 2026
★★★★★ 3
Ugly
Color: 01 - Light Grey
The light blue color looks like a hospital gown. Keeps cool but I don't think I can bear looking at it.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 9, 2026
★★★★★ 5
Cooling pillowcase
Color: 01 - Light Grey
These cooling pillowcases are fabulous. I just have one complaint they snap at the end instead of having a zipper, which could be uncomfortable if you’re laying on that snap. Also, it’s very hard to unfasten.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 5, 2025
recommand products
Presented at ECO 2025: In the SURMOUNT-5 phase 3b trial involving adults with obesity without type 2 diabetes, tirzepatide was superior to semaglutide in reducing body weight and waist circumference. Full trial
21.57
Schedule right now! 🍃 🗓Hours : Flexible appointments, send message to DM for appointments. Address : Montclair CA 91763 📍 Phone: (909) 827- 0330 📞 Rialto CA 92376 📍 Phone: (909) 788-9080 📞
25.02
Tirzepatide Once Weekly for the Treatment of Obesity
26.35
Tirzepatide vs Semaglutide for Obesity – NEJM, May 2025 Relevant to endocrinology, internal medicine, cardiology, obesity medicine • Tirzepatide: −20.2% weight loss at 72 wks • Semaglutide: −13.7% • Greater waist reduction
20.43
In the SURMOUNT-1 trial (published in NEJM in July 2022), adults with #obesity treated with weekly tirzepatide, a glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor
22.92